306 related articles for article (PubMed ID: 26183823)
21. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.
Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC
Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.
Marchiori AC; Casolari DA; Nagai MA
Braz J Med Biol Res; 2008 Jul; 41(7):579-82. PubMed ID: 18641796
[TBL] [Abstract][Full Text] [Related]
23. Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer.
Shyu RY; Chang SC; Yu JC; Hsu SJ; Chou JM; Lee MS; Jiang SY
Anticancer Res; 2005; 25(3c):2453-60. PubMed ID: 16080475
[TBL] [Abstract][Full Text] [Related]
24. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
25. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW
Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855
[TBL] [Abstract][Full Text] [Related]
26. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
27. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
28. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene.
Starlard-Davenport A; Lyn-Cook B; Radominska-Pandya A
Steroids; 2008 Jan; 73(1):139-47. PubMed ID: 17981312
[TBL] [Abstract][Full Text] [Related]
29. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
Xu Y; Song J; Berelowitz M; Bruno JF
Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
[TBL] [Abstract][Full Text] [Related]
30. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Liu Y; Li M; Fang Z; Gao S; Cheng W; Duan Y; Wang X; Feng J; Yu T; Zhang J; Wang T; Hu A; Zhang H; Rong Z; Shakila SS; Shang Y; Kong F; Liu J; Li Y; Ma F
Cancer Immunol Immunother; 2024 May; 73(7):117. PubMed ID: 38713229
[TBL] [Abstract][Full Text] [Related]
31. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
32. Circular RNAs and their associations with breast cancer subtypes.
Nair AA; Niu N; Tang X; Thompson KJ; Wang L; Kocher JP; Subramanian S; Kalari KR
Oncotarget; 2016 Dec; 7(49):80967-80979. PubMed ID: 27829232
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
34. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R; Webster L
Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
[TBL] [Abstract][Full Text] [Related]
35. A novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase.
Ferdinandusse S; Denis S; van Roermund CWT; Preece MA; Koster J; Ebberink MS; Waterham HR; Wanders RJA
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):952-958. PubMed ID: 29287774
[TBL] [Abstract][Full Text] [Related]
36. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
37. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
38. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
39. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
40. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]